Tech Company Financing Transactions

Proacta Funding Round

On 2/23/2010, Proacta raised $1.1 million in funding from private investors.

Transaction Overview

Company Name
Announced On
2/23/2010
Transaction Type
Venture Equity
Amount
$1,100,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
4275 Executive Square 440
La Jolla, CA 92037
USA
Email Address
Overview
Proacta is developing a new generation of cancer drugs that uniquely target physiological attributes of solid tumors.Proacta's first lead program, a hypoxia targeted small-molecule prodrug, is designed to improve the outcomes of current treatment regimens, including chemotherapy and radiotherapy.
Profile
Proacta LinkedIn Company Profile
Social Media
Proacta Company Twitter Account
Company News
Proacta News
Facebook
Proacta on Facebook
YouTube
Proacta on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
John Gutheil
  John Gutheil LinkedIn Profile  John Gutheil Twitter Account  John Gutheil News  John Gutheil on Facebook
Chief Financial Officer
Kevin Torre
  Kevin Torre LinkedIn Profile  Kevin Torre Twitter Account  Kevin Torre News  Kevin Torre on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/23/2010: Luminus Devices venture capital transaction
Next: 2/23/2010: Adura Technologies venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to document every notable VC transaction. VC investment data records reported here come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary